Emma Hajaj

6PUBLICATIONS
71CO-AUTHORS
Molecular targetsCell and nuclear divisionPredictive and prognostic markersCancer diagnosisSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
PDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking Through a Non-canonical cGMP-Dependent Pathway.

|Jul 04, 2024
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Lisha Qiu Jin Lim, Lital Adler, Emma Hajaj

|Jun 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Lisha Qiu Jin Lim, Lital Adler, Emma Hajaj

|Mar 27, 2023
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis.

Omer Goldman, Lital N Adler, Emma Hajaj

|Jun 05, 2021
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.

Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj

|Mar 04, 2020
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.

Emma Hajaj, Galit Eisenberg, Shiri Klein

Pageof 1

Frequent Collaborators

4 joint publications

Ayelet Erez

4 joint publications

Lital N Adler

3 joint publications

Eytan Ruppin

3 joint publications

Moshe Oren